scispace - formally typeset
M

Morten Boysen

Researcher at University of Oslo

Publications -  87
Citations -  4498

Morten Boysen is an academic researcher from University of Oslo. The author has contributed to research in topics: Epidermoid carcinoma & Carcinoma. The author has an hindex of 32, co-authored 87 publications receiving 4193 citations. Previous affiliations of Morten Boysen include Sahlgrenska University Hospital & Oslo University Hospital.

Papers
More filters
Journal ArticleDOI

Quality of Life in Head and Neck Cancer Patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35

TL;DR: The QL Q-H&N35, in conjunction with the QLQ-C30, provides a valuable tool for the assessment of health-related quality of life in clinical studies of H&N cancer patients before, during, and after treatment with radiotherapy, surgery, or chemotherapy.
Journal ArticleDOI

A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data.

TL;DR: The health‐related quality of life of patients with head and neck cancer during and after treatment with radiotherapy, surgery, and chemotherapy is evaluated.
Journal ArticleDOI

A prospective study of quality of life in head and neck cancer patients. Part I: at diagnosis.

TL;DR: The overall aim was to examine the impact on HQL at diagnosis depending on tumor location, stage, sex, and age and to describe HQL longitudinally and determine for which patients and during which period HQL deteriorated most.
Journal ArticleDOI

A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients

TL;DR: The anxiety level was highest at diagnosis, while depression was most common during treatment, and patients under 65 years of age scored higher than those over 65 and patients with lower performance status and more advanced disease reported higher levels of mental distress.
Journal ArticleDOI

Quality of Life and Head and Neck Cancer: A 5 Year Prospective Study†

TL;DR: Assessment of health‐related quality of life (HRQL) in head and neck cancer patients from diagnosis to 5 years after start of treatment finds no significant differences between the periods of diagnosis and treatment.